Search Page

1

Cite

Share

The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?

Yildirim E, Celen O, Berberoglu U. Yildirim E, et al. J Am Coll Surg. 2001 Jan;192(1):25-37. doi: 10.1016/s1072-7515(00)00779-1. J Am Coll Surg. 2001. PMID: 11192920

Cite

Share

2

Cite

Share

Tissue and serum adiponectin levels in patients with gastric cancer: are there any correlations between adiponectin levels and histopathological variables?

Seker M, Bilici A, Guler DO, Ustaalioglu BB, Gozu H, Erkal FY, Sonmez B, Karaduman M, Kefeli U, Yildirim E, Salepci T, Gumus M. Seker M, et al. Among authors: yildirim e. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1841-6. doi: 10.5754/hge10288. Epub 2011 Jul 19. Hepatogastroenterology. 2011. PMID: 21940354

Cite

Share

3

Cite

Share

Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).

Aydin D, Sendur MA, Kefeli U, Umut Unal O, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Bala Ustaalioglu B, Sener Dede D, Esbag O, Inal A, Bilir C, Bilici A, Harputlu H, Berk V, Sevinc A, Yildirim Ozdemir N, Yildirim E, Sonkaya A, Ali Ustaoglu M, Gumus M. Aydin D, et al. Among authors: yildirim e, yildirim ozdemir n. J BUON. 2016 Sept-Oct;21(5):1242-1249. J BUON. 2016. PMID: 27837629 Free article.

Cite

Share

4

Cite

Share

Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.

Aydin D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanrıverdi O, Bilici A, Arpaci E, Berk V, Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M. Aydin D, et al. Among authors: yildirim e. Clin Colorectal Cancer. 2017 Sep;16(3):220-227. doi: 10.1016/j.clcc.2016.08.002. Epub 2016 Aug 30. Clin Colorectal Cancer. 2017. PMID: 27670893

Cite

Share

5

Cite

Share

Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma.

Aydin D, Sendur MA, Kefeli U, Ustaalioglu BB, Aydin O, Yildirim E, Isik D, Ozcelik M, Surmeli H, Oyman A, Isik S, Sener N, Ercelep O, Odabas H, Aliustaoglu M, Gumus M. Aydin D, et al. Among authors: yildirim e. Clin Colorectal Cancer. 2017 Mar;16(1):78-83. doi: 10.1016/j.clcc.2016.04.013. Epub 2016 May 7. Clin Colorectal Cancer. 2017. PMID: 27247089

Cite

Share

6

Cite

Share

Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.

Oven Ustaalioglu BB, Bilici A, Kefeli U, Seker M, Yildirim E, Salepci T, Oncel M, Kement M, Gumus M. Oven Ustaalioglu BB, et al. Among authors: yildirim e. Oncology. 2010;79(1-2):105-11. doi: 10.1159/000320162. Epub 2010 Nov 22. Oncology. 2010. PMID: 21088436

Cite

Share

7

Cite

Share

Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.

Bilici A, Seker M, Ustaalioglu BB, Kefeli U, Yildirim E, Yavuzer D, Aydin FM, Salepci T, Oncel M, Gumus M. Bilici A, et al. Among authors: yildirim e. Ann Surg Oncol. 2010 Aug;17(8):2037-44. doi: 10.1245/s10434-010-1027-y. Epub 2010 Mar 24. Ann Surg Oncol. 2010. PMID: 20333555

Cite

Share

8

Cite

Share

Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?

Bilici A, Ustaalioglu BB, Gumus M, Seker M, Yilmaz B, Kefeli U, Yildirim E, Sonmez B, Salepci T, Kement M, Mayadagli A. Bilici A, et al. Among authors: yildirim e. Onkologie. 2010;33(3):101-5. doi: 10.1159/000277927. Epub 2010 Feb 16. Onkologie. 2010. PMID: 20215800

Cite

Share

9

Cite

Share

Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis.

Korkmaz T, Seber S, Kefeli U, Sari E, Canhoroz M, Oven B, Yildirim E, Yasar N, Aydin D, Balvan O, Sener N, Yuksel S, Mert A, Polat O, Yumuk F, Kanat O, Gumus M, Turhal NS. Korkmaz T, et al. Among authors: yildirim e. Clin Transl Oncol. 2013 Jul;15(7):535-40. doi: 10.1007/s12094-012-0960-6. Epub 2012 Nov 10. Clin Transl Oncol. 2013. PMID: 23143955

Cite

Share

10

Cite

Share

Predictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast carcinoma.

Celen O, Yildirim E, Ozen N, Sonmez C. Celen O, et al. Among authors: yildirim e. Neoplasma. 2006;53(4):347-51. Neoplasma. 2006. PMID: 16830065 Clinical Trial.

Cite

Share